Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed People Living with HIV-1 Aged Over 65 Years-Reference-Cited by-同舟云学术

Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed People Living with HIV-1 Aged Over 65 Years

Published:2023-07-05 Issue: Volume: Page:
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Calza Leonardo¹^ORCID,Colangeli Vincenzo¹,Legnani Giorgio¹,Cretella Silvia¹,Bon Isabella²,Viale Pierluigi¹

Affiliation:

1. Unit of Infectious Diseases, Department of Medical and Surgical Sciences, S.Orsola Hospital, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

2. Unit of Microbiology, Department of Medical and Surgical Sciences, S.Orsola Hospital, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/aid.2023.0046

Reference27 articles.

1. Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study

2. Clinical pharmacokinetics of antiretroviral drugs in older persons

3. The challenge of HIV treatment in an era of polypharmacy

5. Real word outcomes associated with use of raltegravir in older people living with HIV: results from the 60 months follow-up of the RAL-age cohort

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world effectiveness and safety of switching to dolutegravir/lamivudine among people living with HIV‐1 aged over 50 years who are virologically suppressed;HIV Medicine;2024-09-06

2. Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care;HIV/AIDS - Research and Palliative Care;2024-04

3. Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review;Viruses;2024-03-04

4. Risk of Emergent Dolutegravir Resistance Mutations In People Living With HIV: A Rapid Scoping Review;2024-01-07

5. A retrospective study: Can dual ART mitigate the risk of potential drug-drug interactions among PLWH under stable ART?;Turkish Journal of Medical Sciences;2023-10-26